Article Listing - Options for a P&G/Aventis link-up reviewed by broker Natexis

US FDA IMPORT DETENTIONS

13 April 1992

In the first quarter of fiscal 1992, running from October to December 31, 1991, US Food and Drug Administra-tion officials...

GERMAN BPI: MORE PATIENT CHARGES

13 April 1992

The German pharmaceutical industry association, the BPI, has called for the principle under which patients contribute to the cost of...

GROWING EC MARKET FOR HOMEOPATHY

13 April 1992

Addressing the rapid growth which the herbal medicines industry has experienced globally in recent years, international management consultant McAlpine Thorpe...

SUSPENSION OF DPT VACCINE

13 April 1992

Following the decision by the Department of Health in the Republic of China for an immediate temporary suspension of the...

PASTEUR MERIEUX HIB VACCINE

13 April 1992

Pasteur Merieux has launched Hemophilus influenzae type B conjugate vaccine, called Act-HIB, onto the French market.

FORTHCOMING MEETINGS

13 April 1992

Pharmaceutical industry meetings to be held in London by Management Forum shortly include:

- Improving Drug Development: Principles and Practice of...

"ROLLING" NDA FOR ADRIA'S RIFABUTIN

13 April 1992

A New Drug Application for Adria Laboratories' rifabutin, a product under development as a treatment for opportunistic Mycobacterium avium complex...

IMPROVED METERED DOSE INHALER

13 April 1992

Armstrong Pharmaceuticals has signed an exclusive license agreement option for an improved metered dose inhaler from Texax-Glynn Corp. The device...

CONTINENTAL CLOSES BIOLOGICALS DIVISION SALE

13 April 1992

Continental Pharma Cryosan Inc reports that it has received a cash payment of $16.9 million on closing the sale of...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...